drugset / Trial / NCT03037788
Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis
Phase 1
Completed
30 enrolled
Dr. August Wolff GmbH & Co. KG Arzneimittel
Charles River Biopharmaceutical Services GmbH · collabFGK Clinical Research GmbH · collabNuvisan · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the study is to assess the safety, tolerability, pharmacokinetics (PK) and efficacy of escalating concentrations of GPB in subjects with axillary hyperhidrosis.
Timeline
- Start
- 2016-11
- Primary completion
- 2017-06
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrronium | Unknown | — | Topical |